Searched for
WOCKHARDT PROFIT GROWTH
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
- Wockhardt Q2 Results: Co swings to profit at Rs 82 croreDrug firm Wockhardt on Monday reported a consolidated profit after tax of Rs 82 crore for the second quarter ended September 30, 2025.
- Wockhardt Q3 results: Net profit up 69% to Rs 32 croreTotal income stood at Rs 864.56 crore for the quarter under consideration, up 12.89 per cent, as against Rs 765.80 crore for the same perio...
- Wockhardt Q2 net zooms to Rs 108 croreThe company had posted a net profit of Rs 3.63 crore during the corresponding period of the previous fiscal, Wockhardt said in a filing to ...
- Wockhardt Q1 Net dips 14 per cent to Rs 323 croreNet sales rose to Rs 1,358.37 crore for the first quarter, compared to Rs 1,341.44 crore during the same period of previous fiscal.
- Wockhardt Q3 net zooms two-fold to Rs 428 croreThe company had posted a net profit of Rs 213 crore in the same period of previous fiscal.
- Analysts bullish on Wockhardt due to its proven growth potentialPreviously a bankruptcy case, the firm has emerged stronger and is trading at a discount to its peers.
- Wockhardt to repay Rs 200 crore in FCCBs; Q1 net jumps 95%Wockhardt, which today reported 95 per cent jump in net profit in the June quarter, said it would repay the remaining Rs 200-crore of its o...
- Wockhardt clears the debt mess, posts 95% YoY growth in Q1The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.
- Wockhardt Q1 net profit almost doubles at Rs 378 crPharma firm Wockhardt today reported 94.87 per cent rise in consolidated net profit at Rs 377.97 crore for the first quarter.
- Wockhardt hits lifetime high, up 170% in 2012Wockhardt Ltd surged over 6% in trade to hits its lifetime high of Rs 773.00 on Wednesday on the back of steady performance and valuations ...
- Wockhardt’s earnings are likely to continue growing at 25%Investors of Wockhardt Pharmaceutical should not fret much about the reported loss in the quarter to March given the fundamentals of the co...
- Wockhardt Q2 net at Rs 127.58 croreDrug firm Wockhardt today reported a consolidated net profit of Rs 127.58 crore for the second quarter ended September 30, 2011 on improved...
Load More
